Does ERYTHROPOIETIN Cause Diffuse large b-cell lymphoma refractory? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Diffuse large b-cell lymphoma refractory have been filed in association with ERYTHROPOIETIN. This represents 0.5% of all adverse event reports for ERYTHROPOIETIN.
38
Reports of Diffuse large b-cell lymphoma refractory with ERYTHROPOIETIN
0.5%
of all ERYTHROPOIETIN reports
0
Deaths
38
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From ERYTHROPOIETIN?
Of the 38 reports, 38 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROPOIETIN. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROPOIETIN Cause?
Product storage error (1,286)
Death (871)
Circumstance or information capable of leading to medication error (592)
Off label use (590)
Haemoglobin decreased (443)
Drug ineffective (370)
Anaemia (367)
Intercepted product administration error (301)
Incorrect product storage (268)
Fatigue (266)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which ERYTHROPOIETIN Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
ERYTHROPOIETIN vs ESCHERICHIA COLI
ERYTHROPOIETIN vs ESCITALOPRAM
ERYTHROPOIETIN vs ESCITALOPRAM OXALATE
ERYTHROPOIETIN vs ESKETAMINE
ERYTHROPOIETIN vs ESLICARBAZEPINE